Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet transfusions.

David F Stroncek1, Paolo Rebulla

  • 1Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland 20892-1184, USA. dstroncek@cc.nih.gov

Lancet (London, England)
|August 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results.

Journal for immunotherapy of cancer·2026
Same author

Distinct in vivo dynamics of donor-derived stem cell memory CAR T cells post-allogeneic HSCT relapse.

Cell·2026
Same author

Bringing in vivo CAR to the clinic: Promise, pitfalls, and questions to ask.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

A multicentre analysis of efficacy, safety and molecular response correlates of fostamatinib in warm autoimmune haemolytic anaemia and Evans syndrome.

British journal of haematology·2026
Same author

Erratum: Quality and stability studies of red blood cell concentrates from umbilical cord blood compared to their adult counterparts.

Blood transfusion = Trasfusione del sangue·2026
Same author

Alpha-gal sensitization and allergic blood transfusion reactions: a scoping review.

Journal of translational medicine·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

Platelet transfusions are vital for treating various conditions but carry risks like infection and immune reactions. This review covers platelet components, modifications, and practices to improve transfusion safety and effectiveness.

Area of Science:

  • Hematology
  • Transfusion Medicine

Background:

  • Platelet transfusions are essential in treating cancers, hematological malignancies, marrow failure, and stem cell transplants.
  • Over 4.4 million platelet products are transfused annually in the USA and Europe.
  • Despite benefits, platelet transfusions pose risks including infection transmission and immune reactions like alloimmunization.

Purpose of the Study:

  • To review commonly used platelet components and product modifications.
  • To discuss current transfusion practices and their variations.
  • To outline adverse consequences associated with platelet transfusions.

Main Methods:

  • Review of literature on platelet components, modifications, and transfusion practices.
  • Analysis of transfusion indications, dosage, and management of alloimmunized recipients.

Related Experiment Videos

  • Examination of adverse events and complications.

    • Main Results:

    • Several types of platelet components exist, with modifications available to mitigate transfusion complications.
    • Transfusion practices, including indications and dosage, differ significantly across regions.
    • Alloimmunization remains a significant challenge, impacting transfusion effectiveness.

    Conclusions:

    • Understanding platelet components, modifications, and practices is crucial for optimizing transfusion therapy.
    • Addressing variations in transfusion protocols and managing alloimmunization can improve patient outcomes.
    • Further research and standardization of practices are needed to enhance the safety and efficacy of platelet transfusions.